The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
09:42
I don’t know what Scot has said as I have blocked him but I can imagine what he has said. He reminds me of some politicians, they also talk too long. But remember, just because you talk a lot doesn’t make you more intelligent. Or in Scot’s case we can see exactly what he is up to.
13:09
Always going on about potential negatives. For a balanced view why not mention the positives, you know there are.
You post the same on Hot Copper.
As for Scot, can you tell him to condense his essays, more people will read them. Far too long.
The RNS states:
The Company understands Burgundy is in the final stages of securing funding, with Burgundy requesting an extension of time until 15 February 2024 which the Company has agreed to. Burgundy understands there will be no further extensions and that non-payment by mid-February will require Burgundy to transfer to 88E-Accumulate 50% of Burgundy’s working interest (approximately 12.5% working interest) in all of Burgundy’s Project Phoenix’s Toolik River Unit leases (Transfer Interest).
I won’t be. It is strange you turn up when we are about to get ready for the flow test. I have seen you on Hot Copper and I do not believe you have 200+ million. I just think you are here to stir things up.
Have your comments if and when the BOD announces their plan for consolidation.
Latest video out:
https://www.youtube.com/watch?v=jEIRh5rO2HE